Bone Biologics Corporation
BBLG
$0.6899
$0.02393.59%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
3/29/2025
-
Ticker Report
12/26/2024
-
Ticker Report
10/23/2024
-
Ticker Report
10/21/2024
-
Business Wire
9/26/2024
-
Zolmax
9/4/2024
-
Business Wire
8/28/2024
-
Ticker Report
8/15/2024
-
Ticker Report
8/14/2024
-
Zolmax
8/13/2024
-
Ticker Report
8/12/2024
-
SeekingAlpha.com: All News
8/12/2024
-
The Fly
8/12/2024
-
InvestorPlace
8/9/2024
-
InvestorPlace
8/2/2024
-
Seeking Alpha - Healthcare
8/2/2024
-
Business Wire
7/24/2024
-
InvestorPlace
6/21/2024
-
Ticker Report
6/20/2024
-
The Fly
6/20/2024
-
Business Wire
6/17/2024
-
Globe Newswire
6/5/2024
-
InvestorPlace
6/4/2024
-
Zolmax
6/4/2024
-
Ticker Report
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, February 26, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 552 4452
Address
2 Burlington Woods Drive
Burlington, MA 01803
Burlington, MA 01803
Country
Year Founded
Business Description
Sector
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company’s medical device NELL-1/DBM, an osteopromotive...
more